Asthma is a common long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and easily triggered bronchospasms. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. These may occur a few times a day or a few times per week. Depending on the person, asthma symptoms may become worse at night or with exercise.
Components of the Book:
- Chapter 1
The impact of perennial allergic rhinitis with/without allergic asthma on sleep, work and activity level
- Chapter 2
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
- Chapter 3
Allergen immunotherapy for allergic asthma: protocol for a systematic review
- Chapter 4
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
- Chapter 5
Health effects of diesel engine exhaust emissions exposure (DEEE) can mimic allergic asthma and rhinitis
- Chapter 6
Overexpression of programmed cell death 5 in a mouse model of ovalbumin-induced allergic asthma
- Chapter 7
The role of miR-29c/B7-H3 axis in children with allergic asthma
- Chapter 8
Role of the ion channel, transient receptor potential cation channel subfamily V member 1 (TRPV1), in allergic asthma
- Chapter 9
Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting
- Chapter 10
Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience
- Chapter 11
Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting
- Chapter 12
Polymorphisms of two histamine-metabolizing enzymes genes and childhood allergic asthma: a case control study
- Chapter 13
The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma
- Chapter 14
Oral immunotherapy with the ingestion of house dust mite extract in a murine model of allergic asthma
- Chapter 15
Specific histamine binding activity of a new lipocalin from Hyalomma asiaticum (Ixodidae) and therapeutic effects on allergic asthma in mice
Readership:
Students, academics, teachers and other people attending or interested in Allergic Asthma.
Ulugbek Nurmatov
Ulugbek Nurmatov, Systematic Review at Decision Resources Group Abacus International, Oxford, UK
Graham Roberts
Graham Roberts, The David Hide Asthma and Allergy Research Centre, St Mary’s Hospital, Newport Isle of Wight, NIHR Respiratory Biomedical Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK
Moises Calderon
Moises Calderon, National Heart and Lung Institute, Imperial College, London, London, UK
Stan Szefler
Stan Szefler, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, USA
Aziz Sheikh
Aziz Sheikh, Allergy and Respiratory Research Group, The University of Edinburgh, Edinburgh, U
Katie Baker
Katie Baker, Respiratory Pharmacology, Airway Disease Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Exhibition Road, London, UK
and more...